Dentists in Geneva, NE Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. James Trexel, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1008 G St, Geneva, NE 68361 Phone: 402-759-4288 |
Dr. Michael Patrick Sullivan, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1008 G Sreet, Geneva, NE 68361 Phone: 402-759-4288 Fax: 402-759-4470 |
Dr. Raymond Jay Cronk Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 S 10th, Geneva, NE 68361 Phone: 402-759-3097 |
News Archive
Validation of thrombin generation assay (TGA) for an IVIG drug announced by Haemtech Biopharma Services
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
Invivo recognized with 2010 Gold Medical Design Excellence Award
On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.
TSRI scientists reveal molecular secret behind short, intense exercise
In the last few years, the benefits of short, intense workouts have been extolled by both researchers and exercise fans as something of a metabolic panacea capable of providing greater overall fitness, better blood sugar control and weight reduction-all of it in periods as short as seven minutes a few times a week.
'Plastic antibodies' effectively target and eliminate tumor cells
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
› Verified 9 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists